to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin.
Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.
A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis.
A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers.